The relationship between resistant starch and glycemic control: A review on current evidence and possible mechanisms by Louie, CYJ & Wong, THT
Title The relationship between resistant starch and glycemic control:A review on current evidence and possible mechanisms
Author(s) Wong, THT; Louie, CYJ
Citation Starch, 2017, v. 69 n. 7-8, article no. 1600205
Issued Date 2017
URL http://hdl.handle.net/10722/251576
Rights
This is the accepted version of the following article: Starch,
2017, v. 69 n. 7-8, article no. 1600205, which has been published
in final form at
http://onlinelibrary.wiley.com/doi/10.1002/star.201600205/abstrac
t; This work is licensed under a Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License.
The Relationship between Resistant Starch and Glycemic Control: A Review on Current 1 
Evidence and Possible Mechanisms 2 
Tommy Hon Ting Wong BSc MNutrDiet APD, Jimmy Chun Yu Louie BSc MNutrDiet PhD APD 3 
 4 
School of Biological Sciences, Faculty of Science, The University of Hong Kong, Hong Kong Special 5 
Administrative Region, People’s Republic of China 6 
 7 
Address for correspondence 8 
Dr. Jimmy Chun Yu Louie 9 
5S-14 Kadoorie Biological Sciences Building 10 
The University of Hong Kong 11 
1 Pokfulam Road, Pokfulam, Hong Kong SAR 12 
 13 
T: +852 2299 0677 14 
F: +852 2559 9114 15 
E: jimmyl@hku.hk 16 
 17 
No reprints available 18 
 19 
1 
 
List of abbreviations used: RS, resistant starch; RDS, readily digestible starch; HAM-RS2, 20 
high-amylose maize type-2 resistant starch; AUC, area under curve; FFA, free fatty acid; PYY, peptide 21 
YY; GLP-1, glucagon-like peptide-1; GPR, G-protein coupled receptors 22 
Word count: 4494 23 
Running title: Resistant Starch and Glycemic Control 24 
Number of tables: 1 25 
Number of figures 2 26 
Authors’ names for PubMed listing: THT Wong, JCY Louie 27 
 28 
29 
2 
 
Abstract 30 
Good glycemic control, which is vital for patients with type 2 diabetes, could be achieved via dietary 31 
intervention. Resistant starch (RS) is a type of carbohydrate that largely resists digestion in the small 32 
intestine. Instead, it is fermented by the gut microbiota that resides in the large intestine into 33 
short-chain fatty acids (SCFAs), which are found to have beneficial effects on human glucose 34 
metabolism. This review first provides an overview of the classification of different types of RS, as 35 
well as the fermentation process of RS by the gut microbiota. The effects of RS consumption that 36 
contribute to glycemic control were then discussed with reference to animal and human studies. 37 
Although beneficial effects of RS consumption were observed, results from animal and human studies 38 
were inconclusive regarding the mechanisms behind. Additional research effort is necessary in order to 39 
have a better understanding of the effects of habitual RS consumption on glycemic control. 40 
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Introduction 45 
According to the World Health Organization (WHO), chronic high blood glucose is the third largest 46 
reason for premature mortality [1]. It was estimated that in the year of 2015, one in every 11 adults 47 
around the world had diabetes and 12% of the global health expenditure was spent on treating diabetes 48 
[2]. Maintaining glycemic control has been established as the primary treatment goal for diabetes and 49 
pre-diabetes, as it can reduce the chance of complication and mortality [2]. Lifestyle interventions, 50 
including dietary changes, has long been suggested as the primary treatment to enable patients to 51 
manage their blood glucose level [3]. 52 
 53 
Blood glucose level is directly affected by the intake of readily digestible carbohydrates, such as 54 
sucrose and starch, which is the polymer formed by glucose molecules linked together by alpha-1,4 and 55 
alpha-1,6 glycosidic bonds. Starch is mostly digestible in the human gastrointestinal tract, except 56 
resistant starch (RS), which are special forms of starch able to resist digestion in the stomach and small 57 
intestine [4]. Instead, it reaches the large intestine mainly undigested and is fermented by the bacteria 58 
that reside there. Research has shown that RS consumption positively affects blood glucose metabolism 59 
in human [5, 6]. With the recent emergence of human and animal trials regarding the breakdown of 60 
indigestible carbohydrate by the gut microbiota, our understanding of the effect of RS consumption on 61 
blood glucose control has been greatly enhanced. This review provides an update on the evidence and 62 
the mechanisms involved. 63 
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 64 
Classification of Resistant Starch 65 
Englyst et al. [4] classified different types of RS into four main categories, depending on the cause of 66 
resistance to digestion. One new form of resistant starch was discovered later on and became the fifth 67 
type of RS, resulting in the new classification as shown in Table 1. RS1 refers to starch molecules that 68 
are contained in an indigestible outer layer, such as cell wall and protein matrix. RS2 refers to starch 69 
molecules with type B or C polymorph. Molecules in these structures are less susceptible to enzyme 70 
hydrolysis [7]. RS3 refers to starch molecules that have undergone retrogradation i.e. the realignment 71 
of starch molecules upon cooling after gelatinization. Retrograded starch molecules have a higher 72 
gelatinization temperature, and these molecules are unable to fit into the substrate binding site of 73 
amylase [8]. RS4 are starch molecules that have undergone chemical modifications, such as the 74 
addition of cross-linkages or chemical derivatives. These modifications include limiting the ability of 75 
the starch molecule to swell during heating, or changing the structure of the molecule such that it can 76 
no longer fit into the binding site of the digestive enzymes [9]. It was found that the reaction 77 
parameters of RS4, such as the availability of reactant and reaction temperature, could be modified to 78 
control the ability of the molecules produced to resist digestion [10]. RS5 refers to the complex that 79 
consists of a fatty acid molecule and an amylose chain, which are straight chains of glucose molecules 80 
linked together by alpha-1, 4 glycosidic bonds. The complexes then aggregated to form a superstructure, 81 
which were found to be resistant to enzymatic hydrolysis [11, 12].. Figure 1 illustrates the structures of 82 
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different types of RS. 83 
 84 
Fermentation of Resistant Starch by Gut Bacteria 85 
The fermentation of RS in the large intestine is a stepwise process, involving different bacteria. The 86 
outer protective layer (if there is any) is first degraded, then the starch polymers are broken down into 87 
oligosaccharides and the glycolytic processes follow, with short-chain fatty acids (SCFAs) being the 88 
major end products.  89 
 90 
 Studies have shown that the ability of bacteria to adhere to the resistant starch molecules is an 91 
important first step for fermentation, and it was  found that this process involves multiple binding 92 
proteins. For example, the starch-utilization gene (sus) cluster, that was identified in the genome of the 93 
bacteria Bacteriodes thetaiotaomicron, coded for a variety of proteins which were responsible for the 94 
transportation of carbohydrate molecules into the periplasm of the bacterial cell and the breakdown of 95 
the molecule [13]. Cellulosome is another complex which was found to be involved in the digestion of 96 
cellulose, the protective layer which prevents the digestion of starch in RS1. In this complex, different 97 
protein components were found to be responsible for attaching cellulose molecules to the bacterial cell 98 
surface, as well as for the subsequent breakdown of them [14]. Multiple strains of gut bacteria have 99 
been found to utilize this mechanism in starch degradation [14]. In addition, starch binding of some 100 
gram-positive bacteria was found to be accomplished via cell-bound α-amylase [5]. After the adhesion 101 
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of bacterial cells to the starch molecules, enzymes were responsible in cleaving different bonds within 102 
the molecules, such as α-amylase and α-glucosidase for cleaving α-1,4 linkages, and type 1 pullulanase 103 
for cleaving α-1,6 linkages [5, 15]. 104 
 105 
The main products of RS fermentation are SCFAs, which include acetate, propionate and butyrate [16, 106 
17]. It was found that SCFA production mainly happens in the cecum and proximal colon, where the 107 
pH was found to be the lowest [18]. The SCFAs produced were mainly absorbed by colonocytes or 108 
metabolized by other gut bacteria, with only 5-10% of the SCFAs excreted with feces [19]. 109 
 110 
Effects of Resistant Starch Consumption leading to Improved Glycemic Control 111 
RS consumption has been shown to improve glycemic control in both animal and human studies, yet 112 
the mechanisms behind remain poorly understood. Several possible mechanisms are discussed below, 113 
as outlined in Figure 2. 114 
 115 
Reduction in Glycemic Load 116 
The rate of digestion of RS-containing food in the small intestine is much lower when compared with 117 
food containing only readily digestible starch (RDS). As a result, consumption of such food leads to a 118 
sustained and lower level of glucose release [20]. This effect is reflected by the glycemic index (GI), a 119 
ranking system which organizes different food items according to the change of glycemic response 120 
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upon food consumption [21]. Upon inducing retrogradation in the test foods, researchers observed a 121 
decrease in starch digestibility of the treated food when compared with the untreated food [22]. They 122 
also observed a slower rise in blood glucose level in human subjects upon consuming the treated food, 123 
when compared with those consuming the untreated food [22, 23]. 124 
 125 
It should be noted that the beneficial effects on postprandial glucose metabolism upon RS consumption 126 
were observed only when RS replaced RDS, but not when RS was added to RDS (the concept was 127 
shown in figure 3). In a study conducted by MacNeil et al. [24] different test foods were produced by 128 
mixing normal wheat flour and RS2-containing flour at different ratios and were consumed by subjects 129 
with type 2 diabetes. The researchers observed lower incremental area under curves (AUC) and lower 130 
peak levels of postprandial glucose and insulin in subjects who consumed the RS2-containing test food, 131 
which had the same amount of carbohydrate with the control food. This difference was notobserved in 132 
subjects who consumed the other type of test food, which was made by adding RS2 directly to a 133 
portion of control food. Similar findings were seen in a study conducted by Luhovyy et al. [25] whose 134 
team replaced the wheat flour by RS2-containing flour when producing the test food, so that the total 135 
amount of carbohydrate was the same between the treatment food and the control food. Also, they 136 
observed a dose-dependent effect of RS content on postprandial glucose level, such that consuming a 137 
higher dose of RS led to a lower AUC of postprandial glucose curve. On the other hand, in studies 138 
where RS was added as an extra portion to the test foods, the results on postprandial glucose and 139 
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insulin levels were mixed i.e. both positive and negative results were observed [26-28]. The reason 140 
behind this was that the postprandial glucose level was directly affected by the portion of available 141 
carbohydrate, thus adding RS alone without decreasing the available carbohydrate content of the food 142 
may not efficiently decrease postprandial glucose levels [24]. This view was supported by the European 143 
Food Safety Authority (ESFA), which recommended the replacement of digestible carbohydrate by RS 144 
rather than addition for improvement to be observed in postprandial glycemic control [29]. 145 
 146 
Improved Glycemic Response of the Subsequent Meal 147 
RS consumption may also diminish the glycemic response of the subsequent meal when compared with 148 
consuming RDS only (figure 4). MacNeil et al. [24] found that the consumption of RS2-containing 149 
food led to a lower rise in glucose and insulin after the consumption of a subsequent standard meal 150 
three hours later when compared with consuming RDS only. The researchers attributed the improved 151 
response to the increased insulin secretion, which was found to be in line with the variation of the level 152 
of glucose-dependent insulinotropic polypeptide (GIP). However it was previously shown that this 153 
improved postprandial glycemic response after the second meal was not due to the acute insulin 154 
secretion. Instead, an increase in postprandial glycogen storage, which was caused by a suppressed free 155 
fatty acid (FFA) level in the circulation, was proposed to be the real cause [30]. In contrast, Luhovyy et 156 
al. [25] found a higher postprandial AUC of glucose upon consuming the second meal in the treatment 157 
group who consumed RS-containing cookies two hours before. They argued that the release of glucose 158 
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from the previous meal was still ongoing when consuming the second meal, thus leading to the 159 
elevated postprandial glucose level. Although the fact that the second meal being provided ad libitum 160 
affected the results, this view was possible as the digestion time of RS could last for up to seven hours 161 
[20]. More studies are needed to investigate the second meal effect of RS consumption, with the 162 
nutrition profile of the second meal standardized for a valid comparison. 163 
 164 
Improvements in Muscular and Hepatic Glucose Handling 165 
The SCFA produced upon the fermentation of RS by the gut microbiota have profound effects on 166 
glucose homeostasis in liver and muscle tissues. G-protein coupled receptors (GPR) 41 and 43, which 167 
are SCFA receptors, have been found on both muscle and liver cell membranes Activation of GPR 168 
41/43 by SCFAs has been found to lead to an increase in glucose uptake and glycogen storage at 169 
muscle tissues [18]. 170 
 171 
Unfortunately, studies investigating the effect of RS consumption and the impact of glucose 172 
homeostasis in muscle tissues were scarce. Robertson et al. [31] fed an extra 30g of RS2 on top of an 173 
RDS portion to a group of healthy subjects, while the other group had only the RDS portion in their 174 
diet, for 12 weeks. Their postprandial glucose clearance in the muscle was measured by analyzing the 175 
arterialized venous blood collected at the contralateral forearm. The researchers found that subjects 176 
who consumed RS had improved in muscle glucose clearance and insulin sensitivity, as well as a 177 
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concomitant increase in SCFA uptake at muscle, when compared with patients consuming only RDS. 178 
Nonetheless, the AUCs of glucose levels upon receiving meal challenges were not different between 179 
the two groups. On the other hand, Bodinham et al. [32] fed an additional 40g of RS2 to subjects with 180 
type 2 diabetes (T2DM) when compared with the control group. They observed a higher glucose uptake 181 
in the muscles in the RS group, although this was not statistically significant. However, they found that 182 
the plasma level of propionate and acetate in the RS-consuming subjects were lower. They argued that 183 
the lower plasma level of SCFAs could be the result of an increased uptake by the peripheral tissues, 184 
which was observed in a previous study [31]. In contrast to the previous study, they observed lower 185 
postprandial glucose AUCs for the RS group, when compared with the group without RS consumption. 186 
Owing to the inconclusive results, more studies are needed to further establish the role of SCFA in 187 
affecting the glucose handling of muscle, as well as the impact of such changes towards the overall 188 
glucose homeostasis. 189 
 190 
In addition, since SCFAs have been shown to positively affect the glucose homeostasis of liver [18], it 191 
is possible for such benefits to also be conferred by RS consumption. Unfortunately to date there was 192 
no human study that looked at this effect, and animal studies were scarce in this regard. Polakof et al. 193 
[33] fed a batch of rats with a high-fat diet and replaced the carbohydrate portion of the test diet with 194 
RS2 for some of the rats. They found that in rats which consumed both the high-fat diet and RS, hepatic 195 
insulin sensitivity was improved, and the liver inflammation statuses were alleviated. This 196 
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improvements were not observed in rats consuming a high-fat diet without RS replacement. 197 
Furthermore, the activities of hepatic enzymes involved in glycolysis (e.g. glucokinase and pyruvate 198 
kinase) were found to be reduced by consuming the high-fat diet, yet this was partially restored by RS 199 
consumption [33]. Given the central role of liver in maintaining blood glucose level and glucose 200 
homeostasis in human [34], the effect of RS consumption on hepatic glucose handling warrants further 201 
investigation. More trials are needed to confirm the relationship between RS consumption and hepatic 202 
glucose metabolism on human. 203 
 204 
Increase Insulin Sensitivity by Reducing Adiposity 205 
Overweight and obesity have long been referred to as a risk factor for insulin resistance and T2DM. 206 
The prolonged excess in energy intake leads to ectopic fat storage, i.e. fat deposits around internal 207 
organs in the abdominal area. This condition was found to inducelocal and systemic insulin resistance 208 
via the induction of abnormal inflammation pathways [18, 35]. Moreover, the hypertrophic growth (i.e. 209 
expansion in size) of adipocytes, which also results from a prolonged oversupply of energy, is related to 210 
the development of insulin resistance as well [36, 37]. This is due to the stress induced by the rapidly 211 
expanded adipose tissues as they are inadequately vascularized. As a consequence, the inflammatory 212 
pathways in those stressed adipocytes become activated, and the secretion of pro-inflammatory 213 
cytokines increases, thus interfering with insulin signaling pathways [38]. RS consumption has been 214 
associated with a lower mass of adipose tissues and the suppression of inflammatory pathways (figure 215 
12 
 
5). 216 
 217 
Animal studies were able to demonstrate the beneficial effects of RS consumption on fat metabolism 218 
and glucose and insulin tolerance. For instance, Harazaki et al. [39] fed obese rats with a diet with 55% 219 
(w/w) high-amylose maize type-2 RS (HAM-RS2) for four weeks and observed improvements in 220 
insulin sensitivity, when compared with rats fed the control diet (55% cornstarch instead of HAM-RS2). 221 
They also found that the size of the mesenteric adipocytes in RS2-fed rats was smaller than those fed 222 
the control diet. In addition, the mRNA levels of molecules related to the inflammation of adipose 223 
tissues were found to be lower in RS-fed rats. Apart from that, Polakof et al. [33] conducted a 9-week 224 
feeding trial on three groups of Wistar rats: one group was fed a low-fat diet (5% fat), one consumed 225 
the high-fat diet (30.4% fat), and the other group consumed the high-fat diet with HAM-RS2 replacing 226 
the carbohydrates (41.6% w/w). They found that the group which consumed the high-fat diet showed 227 
the greatest glucose excursion and insulin secretion, while both measurements for the RS group were 228 
similar to the low-fat diet group. Moreover, genes coding for important proteins involved in fatty 229 
oxidation (e.g. PPAR1) were down-regulated, and those coding for proteins involved in lipogenesis (e.g. 230 
SREBP-1c) were up-regulated in the high-fat diet group when compared with the low-fat diet group. 231 
These elevated expressions were not shown in the RS group. Results from these studies showed that RS 232 
consumption lowered the abdominal fat mass, alleviated the inflammatory status and improved the 233 
insulin resistance caused by the consumption of a high-fat diet. 234 
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 235 
Meanwhile, results from human studies have been inconclusive, such that the improvements in glucose 236 
metabolism did not always occur with improvements in adipose tissue weight or release of 237 
pro-inflammatory cytokines. The trial by Robertson et al. [31] showed positive results: they observed 238 
improvements in insulin sensitivity using euglycemic-hyperinsulinemic clamp(s) in a group of subjects 239 
adding 30g RS2 into their diet every day for 12 weeks, over those who did not incorporate RS into their 240 
diet. They also found that the postprandial output of triacylglycerol (TAG) from adipose tissues and the 241 
rate of action of hormone-sensitive lipase decreased in the treatment group. Yet in some studies, 242 
changes in anthropometric measurements and adipose tissue content were not detected [28, 40, 41], and 243 
the release of pro-inflammatory cytokines were found to be similar between treatment group and 244 
control group [32, 40, 41]. For example, in the feeding trial conducted by Maki et al. [41], participants 245 
(overweight adults) received different treatments: consuming only RDS, an extra 15g or extra 30g/day 246 
of HAM-RS2 (~60% RS2) in a randomized crossover manner. At the end of the study, no difference in 247 
body weight and waist circumference was observed. Moreover, improvement in insulin sensitivity was 248 
only observed in male subjects, while no difference in fasting levels of pro-inflammatory cytokines was 249 
observed between treatment conditions. In another 12-week feeding trial conducted by Johnston et al. 250 
[28] on insulin resistant adults, one group consumed an extra 40g of HAM-RS2 while the other group 251 
consumed only RDS. It turned out that the body weight and fat storage on all body locations measured 252 
were not significantly different between the two groups. Also, no variation was seen in fasting levels of  253 
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inflammatory factors (e.g. IL-6 and hsCRP). However, the insulin sensitivity was improved for the 254 
group consuming HAM-RS2. The results from human studies may imply that the relationship between 255 
improvement in adiposity and the improved insulin sensitivity is more indirect than it is previously 256 
assumed. 257 
 258 
Several explanations were provided for the inconsistent results in terms of the changes in adiposity and 259 
insulin sensitivity upon consuming RS. Some argued that this is because the treatment dosage used in 260 
animal studies were too high for human consumption (up to 50% w/w), thus hindering the translation 261 
of results into human studies [28]. Also in mice studies since RS were fed shortly after the mice were 262 
born, adipose tissue remodeling and a lower ectopic fat storage could take place with growth. On the 263 
other hand, adipose tissues in human were already in situ at the beginning of the studies, thus the 264 
changes in adiposity may be less visible [28]. It is also worth to note that while some studies included 265 
the level of free fatty acid (FFA) in circulation as a study outcome, it has been argued that high FFA 266 
levels per se do not lead to insulin resistance [38]. It has been found that in obese individuals, 267 
hyperinsulinemia may be a mechanism to suppress FFA release, while the release of FFA decreased 268 
with the expansion in the mass of adipose tissues [42]. Alternative hypotheses for the impaired insulin 269 
sensitivity in the context of overweight or obesity, such as the abnormal adipose fat storage and the 270 
dysfunction in the release of adipokines and cytokines, have been proposed [42]. 271 
 272 
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Effects on Gut Hormone Release 273 
Another possible mechanism where RS consumption may impact on blood glucose control is via the 274 
induction of gut hormone release, mainly glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). 275 
GLP-1, secreted by intestinal L-cells, is a type of incretin hormone able to stimulate insulin secretion 276 
and inhibit glucagon secretion [43]. GLP-1 is also related to pancreatic beta-cell proliferation and the 277 
enhancement of peripheral insulin sensitivity [43]. PYY, which has been found to be expressed both in 278 
the GI tract and in the pancreas, is initially found to inhibit appetite thus lowering energy intake [44]. 279 
Nonetheless, in recent studies it has also been found to exhibit paracrine and exocrine effects on 280 
pancreatic islet cells, leading to enhanced insulin secretion [44]. The releases of both hormones are 281 
triggered by the presence of nutrients in the intestinal lumen, which is detected by membrane-bound 282 
transporters found on enterocytes along the intestinal lining [45]. In recent studies, SCFA receptors 283 
were found to be present in the distal gut and were associated with enhanced GLP-1 and PYY secretion 284 
[18] (figure 5). 285 
 286 
In animal studies, both increase [46-48] and decrease [49] in serum level of GLP-1 and PYY had been 287 
found when comparing between animals consuming diets with RS and those with digestible cornstarch 288 
as a control, while the effect on blood glucose homeostasis and insulin sensitivity varied. For example, 289 
Zhou et al. [46] fed healthy rats with either RS2 (30% of diet) or normal cornstarch for 10 days and 290 
found that the serum levels of GLP-1 and PYY in the RS group were elevated throughout the day of 291 
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data collection when compared with the group consuming cornstarch as a control. In the same study, a 292 
separate group of rats received the same dietary treatments, followed by streptozocin injections in order 293 
to induce diabetes. The RS group showed improved glucose tolerance when compared with the 294 
cornstarch group. In contrast, da Silva et al. [49] showed that after feeding pigs with retrograded starch 295 
(RS3, 35% of diet) for 14 days, the postprandial level of GLP-1 decreased while that of PYY did not 296 
change, when compared with pigs fed the similar amount of readily digestible cornstarch. Nonetheless, 297 
they found a lower postprandial insulin and glucose response in the RS group. They argued that the 298 
lowered bioavailability of nutrients in the food, as a result of RS replacing the readily-digestible 299 
carbohydrates, caused a diminished release of gut hormones [49]. This view was supported by another 300 
RS consumption study carried out on pigs [16]. In that study when comparing the pigs that were fed an 301 
RS diet (RS2, 11.3% w/w) for six days with those that were fed a low fibre diet (0.7% diet) for the 302 
same period of time, they found improvements on postprandial blood glucose and insulin level, despite 303 
no difference in GLP-1 level between treatment groups [16].  304 
 305 
The mixed results of animal studies may partly be due to the physiological differences between the 306 
animal models and the different types and doses of the RS used. Nonetheless, the inconsistent results 307 
between RS consumption and the effect of GLP-1 and PYY may imply a more complicated association 308 
between gut hormone release stimulated by RS consumption and glucose homeostasis. The 309 
mechanisms in how RS consumption changes the release of gut hormones, as well as its subsequent 310 
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metabolic effects on animal models warrant further investigation. 311 
 312 
Findings from acute feeding studies on human have been inconsistent. In a study run by Bodinham et al. 313 
[27] a group of healthy adults was fed a test meal with 48g of RS2, while the other group consumed 314 
cornstarch instead of RS2 in the meal. The level of postprandial GLP-1 in the RS group is lower than 315 
those who consumed the control meal, yet the level of postprandial glucose and insulin did not differ 316 
between treatments. In another study, Klosterbuer et al. [26] showed that healthy subjects who 317 
consumed a standard breakfast with 25g RS3 added had a lower postprandial GLP-1 level, as well as a 318 
lower postprandial glucose and insulin level when compared with subjects consuming only the standard 319 
breakfast. Edwards et al. [50] provided two dishes for two groups of ileostomy patients, one being a 320 
wheat porridge made of coarse durum wheat flour (test meal) and the other made with fine durum 321 
wheat flour (control meal, the test meal had 33% lower digestible starch content than the control meal). 322 
They found that patients consuming the test meal had a lower postprandial glucose level and a lower 323 
GLP-1 and PYY level when compared with patients consuming the control meal, although that was not 324 
statistically significant. They argued that the lowered digestibility of the test meal decreased the amount 325 
of available nutrients, thereby reducing the release of GLP-1 and PYY [50]. However as SCFAs 326 
resulted from fermentation by the gut microbiota have also been linked to gut hormone release [18], it 327 
is possible that gut hormones produced in this pathway compensated for the suppressed secretion of gut 328 
hormones due to a lower bioavailability of nutrients. 329 
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 330 
Similarly, studies about long-term RS consumption and its effect on GLP-1 release and glucose level 331 
on human yielded inconsistent results. Robertson et al. [31] found no effect upon including RS in meals 332 
for 12 weeks on GLP-1 level, yet improvement in glucose clearance and insulin sensitivity was 333 
observed. Another 12-week study ran by Bodinham et al. [32] on subjects with type 2 diabetes found 334 
that subjects receiving the treatment food had elevated fasting GLP-1 level but lowered GLP-1 level 335 
after a meal, while a smaller postprandial glycemic variation was also observed.  336 
 337 
In light of the inconsistent findings from acute feeding studies, it has been proposed that a longer study 338 
duration is needed for a better exhibition of the beneficial effects of RS consumption and to determine 339 
the effective dose [27, 28, 51]. Since the human gut microflora takes time to adapt to the continuous 340 
addition of RS in diet [52], the mixed results may not be truly reflecting the effects of RS consumption. 341 
Long term consumption studies would hopefully be able to add on to the body of evidence regarding 342 
the effect of RS consumption towards gut hormone secretion, as well as the subsequent effects on 343 
human glucose homeostasis. 344 
 345 
Conclusion 346 
The beneficial effects of RS consumption on glycemic control have been widely observed in animal 347 
and human studies, yet the mechanisms behind were still poorly understood. Several mechanisms 348 
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behind the impact that RS consumption might have on glycemic control were assessed in this review, 349 
yet the evidence was inconclusive – some effects of RS consumption were being shown only in animal 350 
studies but not in human studies. Several reasons could be possible, including the difficulty in 351 
controlling the baseline parameters in human subjects, such as adiposity and gut microbiota profile, as 352 
well as the fact that the amount of RS used in animal studies may not be suitable or effective for human 353 
consumption. Nonetheless, it should be noted that glucose level is influenced by several factors at the 354 
same time, including absorption, clearance, and release from internal organs, thus carefully planned 355 
studies with suitable controls are vital for reliable and valid results. Additional research efforts are 356 
required to further establish the mechanisms behind the beneficial effects of RS consumption towards 357 
glycemic control. 358 
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Figure legends 519 
Figure 1 – different types of RS. (a) the structure of RS1: the starch molecules were encapsulated by a 520 
physical barrier; (b) B-polymorph of starch molecules. The helical amylose chains, as depicted by 521 
circles, are closely and orderly aligned, enabling the structure to resist enzyme degradation; (c) the 522 
process of retrogradation, thereby forming RS3; (d) cross-linkages in RS4 and (e) starch molecules 523 
linked by a new functional group, e.g. acetyl group or phosphate group, forming another type of RS4; 524 
(f) the structure of RS5. The complex is formed by an amylose chain wrapping around a fatty acid 525 
molecule. Multiple complexes aggregate into forming a superstructure, which is resistant to enzyme 526 
degradation. 527 
Figure 2 – concept map of the effects of RS consumption. RS, resistant starch; CHO, carbohydrate; 528 
SCFAs, short chain fatty acids; PYY, peptide YY; GLP-1, glucagon-like peptide-1 529 
 530 
Figure 3 – the difference in effects between (a) consuming RDS only, (b) replacing RDS with RS, 531 
keeping the same amount of total carbohydrate as control, and (c) addition of RS as an extra portion to 532 
RDS. RS, resistant starch; RDS, readily digestible starch. 533 
 534 
Figure 4 – inclusion of RS in the first meal leads to a lower rise of postprandial glucose after 535 
consuming a standardized second meal. RDS, readily digestible starch; RS, resistant starch. 536 
 537 
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Figure 5 – the benefits conferred by RS consumption via SCFA production. Broken lines depicts 538 
progression, while solid lines depicts enhancement and inhibition. RS, resistant starch; SCFA, 539 
short-chain fatty acid; PYY, peptide YY, GLP-1, glucagon-like peptide-1, GPR, G-protein coupled 540 
receptors. 541 
 542 
543 
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Table 1. Classification of RS and examples [4, 9, 53] 544 
Classification Description Example 
RS1 Physically inaccessible starch Whole grains 
RS2 Starch with B- or C-polymorph Uncooked potato, high-amylose maize (HAM) 
starch 
RS3 Retrograded starch Cooked and cooled potato starch 
RS4 Chemically modified starch Cross-linked starch in thickeners 
RS5 Amylose-lipid complex Palmitic acid-amylose complex 
 545 
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